Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ERGO
Entia Biosciences
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
$0.06
$0.04
$0.27
$38.94M4.2183,144 shs257,300 shs
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
$0.03
$0.03
$0.00
$0.04
$1.31M1.821,051 shsN/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
$0.00
$0.00
$0.00
N/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
$0.04
-14.0%
$0.04
$0.01
$0.13
$2.38M-12.386,655 shs3,200 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ERGO
Entia Biosciences
0.00%0.00%0.00%0.00%-50.00%
Exactus Inc stock logo
EXDI
Exactus
0.00%0.00%0.00%0.00%0.00%
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
0.00%0.00%+6.25%+36.00%+183.33%
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ERGO
Entia Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
N/AN/AN/AN/AN/AN/AN/AN/A
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
N/AN/AN/AN/AN/AN/AN/AN/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ERGO
Entia Biosciences
N/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
N/AN/AN/AN/A
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
N/AN/AN/AN/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ERGO
Entia Biosciences
N/AN/AN/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
$2.07M0.00N/AN/A($0.09) per share0.00
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
$8.40M0.16N/AN/A($3.62) per share-0.01
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/AN/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
$2.33M1.02N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ERGO
Entia Biosciences
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
-$9.46MN/AN/AN/AN/AN/A-3,272.69%-185.29%N/A
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
-$25.42M-$0.63N/AN/A-360.52%N/A-146.03%N/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
$530KN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ERGO
Entia Biosciences
N/AN/AN/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
N/AN/AN/AN/AN/A
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
N/AN/AN/AN/AN/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/AN/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ERGO
Entia Biosciences
N/AN/AN/A
Exactus Inc stock logo
EXDI
Exactus
N/A
1.32
0.82
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
N/A
0.03
0.02
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/AN/AN/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
ERGO
Entia Biosciences
N/A
Exactus Inc stock logo
EXDI
Exactus
0.12%
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
N/A
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
N/A
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ERGO
Entia Biosciences
6N/AN/ANot Optionable
Exactus Inc stock logo
EXDI
Exactus
4599.01 million209.65 millionNot Optionable
GLG Life Tech Co. stock logo
GLGLF
GLG Life Tech
8638.39 millionN/ANot Optionable
Rock Creek Pharmaceuticals, Inc. stock logo
RCPIQ
Rock Creek Pharmaceuticals
5N/AN/ANot Optionable
TBG Diagnostics Limited stock logo
TDLAF
TBG Diagnostics
N/A55.29 millionN/ANot Optionable

GLGLF, ERGO, TDLAF, EXDI, and RCPIQ Headlines

Media Sentiment Over Time

Company Descriptions

Entia Biosciences

OTCMKTS:ERGO
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Exactus logo

Exactus

OTCMKTS:EXDI
Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.
GLG Life Tech logo

GLG Life Tech

OTCMKTS:GLGLF
GLG Life Tech Corporation engages in the research, development, growing, refining, and production of natural sweeteners extracted from the stevia plant and monk fruit worldwide. The company also offers P-Pro Plus, a pea protein product; and natural ingredients. It serves in the food and beverage industry. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was incorporated in 1998 and is headquartered in Richmond, Canada.
Rock Creek Pharmaceuticals logo

Rock Creek Pharmaceuticals

OTCMKTS:RCPIQ
Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL.
TBG Diagnostics logo

TBG Diagnostics

OTCMKTS:TDLAF
TBG Diagnostics Limited, a molecular diagnostics company, develops, manufactures, and markets molecular diagnostics kits, instruments, and services in Taiwan and China. It provides ExProbe HLA and HPA kits for human leukocyte antigen (HLA) and human platelet antigens (HPA) allele genotyping, which uses real time polymerase chain reaction (PCR) techniques with sequence specific primers and probes; Morgan SSP HLA kits for determining HLA alleles using PCR techniques with sequence specific primers; HLAssure SBT HLA Kits for transplantation donor selection; and AccuType SBT analysis software to analyze sequences from all ab1 based files. The company also offers Morgan SSPal HLA Typing Analysis Software, a gel result interpretation software; HLA typing services that offer low to high resolution using PCR fragment analysis (SSP) and DNA sequencing (SBT); QPCR Q6000, a six-channel real time PCR instrument; QzNGS NGS that provides high resolution HLA genotyping; and COVID-19 testing kits. It serves clinical labs, blood centers, and bone marrow registry labs. The company was formerly known as Progen Pharmaceuticals Limited and changed its name to TBG Diagnostics Limited in December 2015. TBG Diagnostics Limited was incorporated in 1989 is based in Greenslopes, Australia.